CD28 and asthma: CD28-mediated co-stimulation has been linked to allergic airway inflammation in pre-clinical models [55], but a randomized trial on patients with asthma failed to demonstrate an effect of treatment with the selective costimulatory modulator abatacept, that blocks the interaction with CD28 on T cells [56].